Related references
Note: Only part of the references are listed.Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis
Eun-Young Cho et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice
Susana Sanchez-Fidalgo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Evaluation of Aloin and Aloe-Emodin as Anti-Inflammatory Agents in Aloe by Using Murine Macrophages
Mi-Young Park et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2009)
Trefoil factor-3 expression in human colon cancer liver metastasis
Mark Babyatsky et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Curcumin has Bright Prospects for the Treatment of Inflammatory Bowel Disease
Hiroyuki Hanai et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Colitis-Associated Variant of TLR2 Causes Impaired Mucosal Repair Because of TFF3 Deficiency
Daniel K. Podolsky et al.
GASTROENTEROLOGY (2009)
Tomato Lycopene Extract Prevents Lipopolysaccharide-Induced NF-κB Signaling but Worsens Dextran Sulfate Sodium-Induced Colitis in NF-κBEGFP Mice
Young-Eun Joo et al.
PLOS ONE (2009)
A comparison of the effects of kaempferol and quercetin on cytokine-induced pro-inflammatory status of cultured human endothelial cells
Irene Crespo et al.
BRITISH JOURNAL OF NUTRITION (2008)
Flavonols from Pterogyne nitens and their evaluation as myeloperoxidase inhibitors
Luis Octavio Regasini et al.
PHYTOCHEMISTRY (2008)
Are we giving biologics too much time? When should we stop treatment?
Edouard Louis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis
H. -S. Kwon et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease:: preclinical and clinical developments
Alexandra Hicks et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Rodent IRR-219 (IgGFcγBP) and rTFF3, expressed mainly in the intestinal mucosa, depleted during dextran sulfate sodium-induced colitis
Zao-Ming Feng et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Mechanism of inhibition of human secretory phospholipase A2 by flavonoids:: rationale for lead design
Jens Laettig et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23→IL-17 axis
Amir F. Sheibanie et al.
JOURNAL OF IMMUNOLOGY (2007)
Dietary flavonoid intake and breast cancer risk among women on long island
Brian N. Fink et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Inflammatory bowel disease: Current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics
Mark S. Geier et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2007)
The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration
Guang-Liang Jiang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis
Haim Shapiro et al.
GUT (2007)
Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappa B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappa B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages
Mari Hamalainen et al.
MEDIATORS OF INFLAMMATION (2007)
TFF (trefoil factor family) peptides and their potential roles for differentiation processes during airway remodeling
Werner Hoffmann
CURRENT MEDICINAL CHEMISTRY (2007)
Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis
S Kawanishi et al.
BIOLOGICAL CHEMISTRY (2006)
Role of pancreatic trypsin in chronic esophagitis induced by gastroduodenal reflux in rats
Y Naito et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Efficacy of conventional immunosuppressive drugs in IBD
R Caprilli et al.
DIGESTIVE AND LIVER DISEASE (2004)
Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility
A Nakao et al.
GUT (2003)
Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants
L Kruidenier et al.
JOURNAL OF PATHOLOGY (2003)
Effect of nimesulide on acetic acid- and leukotriene-induced inflammatory bowel disease in rats
VP Singh et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2003)
Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2001: A KASID study
SK Yang et al.
GASTROENTEROLOGY (2003)
Strategies for targeting tumour necrosis factor in IBD
WJ Sandborn
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2003)
The biochemistry and medical significance of the flavonoids
BH Havsteen
PHARMACOLOGY & THERAPEUTICS (2002)
Epidemiology of inflammatory bowel disease in Asia
SK Yang et al.
INFLAMMATORY BOWEL DISEASES (2001)
Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease
KB Hahm et al.
GUT (2001)
Share Paper
